Assessing Efficacy of Intensive Statin Therapy and Addition Of Non-statin Therapy as a Lipid Lowering Therapy if LDL is Greater Than or Equal To 70 mg/dL In Patients With Atherosclerotic Cardiovascular Disease (ASCVD)
Latest Information Update: 14 Dec 2020
At a glance
- Drugs Ezetimibe (Primary) ; Antihyperlipidaemics
- Indications Atherosclerosis; Dyslipidaemias; Hyperlipidaemia
- Focus Therapeutic Use
Most Recent Events
- 17 Nov 2020 Two year results (n=5006) presented at the American Heart Association Scientific Sessions 2020
- 16 Dec 2019 New trial record
- 18 Nov 2019 Results (N=5006), assessing efficacy of intensive statin therapy and addition of non-statin therapy as a lipid lowering therapy if LDL-C is greater than or equal to 70 mg/dL in patients with ASCVD, presented at the American Heart Association Scientific Sessions 2019